Harm Reduction International

Harm Reduction International
Name	Harm Reduction International
Type	Non-governmental organization
Founded	1997
Location	London, United Kingdom
Region served	Global
Focus	Public health; drug policy; human rights; harm reduction

Harm Reduction International

Harm Reduction International is an NGO based in London focused on reducing health-related harms associated with drug use, with an emphasis on evidence-based policy, human rights, and global advocacy. It engages with international bodies, national ministries, advocacy networks, and academic institutions to influence drug policy, public health strategies, and human rights instruments. The organization collaborates with a wide array of partners across continents to produce research, convene stakeholders, and run campaigns promoting pragmatic responses to substance use.

History

Founded in 1997 amid growing international attention to HIV/AIDS and injection-related transmission, the organization emerged during debates involving the World Health Organization, Joint United Nations Programme on HIV/AIDS, and regional public health agencies. Early activities intersected with campaigns led by Médecins Sans Frontières, International Red Cross and Red Crescent Movement, and community networks in cities such as London, New York City, and Vancouver. Over time the group engaged with policy forums convened by the United Nations General Assembly Special Session on HIV/AIDS and the United Nations Commission on Narcotic Drugs, responding to shifts in discourse influenced by actors like Amnesty International, Human Rights Watch, and the Global Commission on Drug Policy. Notable collaborations involved research partnerships with universities such as University College London, Johns Hopkins University, and University of Oxford, and advocacy alliances with networks including the International Drug Policy Consortium and the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Mission and Activities

The stated mission centers on promoting evidence-based approaches to reduce mortality, morbidity, and social harms related to drug policies, aligning with frameworks advanced by the Universal Declaration of Human Rights and instruments like the International Covenant on Economic, Social and Cultural Rights. Activities include policy analysis, capacity building for civil society groups such as Hepatitis C Trust, technical support to agencies like the European Centre for Disease Prevention and Control, and engagement with regional bodies including the African Union and the Organization of American States. The organization provides training for frontline services modeled after programmes in Portugal and Switzerland, supports legal advocacy intersecting with courts such as the European Court of Human Rights, and liaises with funders such as the Open Society Foundations and philanthropic initiatives like the Bill & Melinda Gates Foundation.

Advocacy and Policy Impact

Advocacy work targets multilateral processes including sessions of the United Nations General Assembly, the World Health Assembly, and deliberations at the Commission on Narcotic Drugs. The organization has contributed evidence to policy debates influenced by reports from bodies like the Office of the United Nations High Commissioner for Human Rights and the United Nations Office on Drugs and Crime. It has campaigned alongside civil society coalitions that include Global Network of People Living with HIV and International Civil Society Action Network, and has intervened in national reform debates in jurisdictions such as Mexico, Philippines, and Russia. Engagements often cite precedents set in jurisdictions like Netherlands and Czech Republic and court rulings by tribunals such as the Inter-American Court of Human Rights.

Programs and Campaigns

Programs encompass global campaigns addressing overdose prevention, supervised consumption, and access to opioid agonist therapy, drawing on models developed in Australia, Canada, and Germany. Campaigns have promoted naloxone distribution policies linked to initiatives from U.S. Centers for Disease Control and Prevention and community responses coordinated with groups like the National Harm Reduction Coalition. Other efforts focus on hepatitis C treatment scale-up referencing programs in Egypt and prison-based interventions informed by studies in Norway and Scotland. The organization has convened international conferences alongside partners such as International AIDS Society and coordinated regional training with entities like the Pan American Health Organization.

Research and Publications

The organization produces annual reports, policy briefings, and technical guidance informed by collaborations with academic centers including London School of Hygiene & Tropical Medicine, Columbia University, and Karolinska Institutet. Publications analyze data from surveillance systems like those maintained by the European Monitoring Centre for Drugs and Drug Addiction and evaluate interventions using methodologies referenced in journals such as The Lancet, PLOS Medicine, and BMJ. Research outputs inform submissions to treaty bodies including the Human Rights Committee and have been cited in reports by the Global Commission on Drug Policy and the World Bank.

Governance and Funding

Governance comprises a board of trustees drawn from public health, law, and advocacy sectors with connections to institutions like King's College London, University of Toronto, and Harvard University. Funding sources include philanthropic foundations such as the Open Society Foundations, grants from multilateral funds like the Global Fund to Fight AIDS, Tuberculosis and Malaria, and project-specific support from agencies including United States Agency for International Development and the European Commission. Partnerships span NGOs such as Médecins du Monde, academic partners like Imperial College London, and policy organizations including the Brookings Institution.

Category:Non-governmental organizations based in the United Kingdom Category:Public health organizations Category:Drug policy reform